WeVote
Log In

Bill

Bill

SCR 23

A CONCURRENT RESOLUTION urging Kentucky's congressional delegation to support amending the Gun Control Act of 1968 to allow users of medical cannabis to exercise their Second Amendment right to bear arms.

2025 Regular Session

Kentucky urges Congress to amend federal gun law allowing state-legal medical cannabis users to own firearms despite federal prohibition.

to Veterans, Military Affairs, & Public Protection (S)
#cannabis #federallawsandregulations #firearmsandweapons
0
WeVote Research Nonpartisan
Bill Summary · SCR 23

Legislative bill overview

SCR 23 is a concurrent resolution asking Kentucky's U.S. congressional representatives to support amending federal gun law to permit medical cannabis users to legally own firearms. Currently, federal law prohibits anyone who uses controlled substances—including medical marijuana—from possessing guns, even in states where medical cannabis is legal. This resolution seeks to change that federal prohibition.

Why is this important

This addresses a genuine conflict between state and federal law: Kentucky allows medical cannabis use, but federal law creates a blanket firearms prohibition for all cannabis users regardless of medical status. The resolution highlights the tension between Second Amendment rights and federal drug policy, affecting Kentucky residents who are state-compliant medical cannabis users but face federal firearms restrictions.

Potential points of contention

  • Federal vs. state authority: The resolution advocates changing federal law, which is Congress's domain, raising questions about whether a state concurrent resolution effectively influences federal legislative priorities
  • Public safety concerns: Opponents may argue that cannabis use and firearm ownership shouldn't be combined, citing impaired judgment risks, while supporters contend medical users differ from recreational users
  • Selective carve-out precedent: Creating a medical cannabis exemption while maintaining restrictions on other substance users could be challenged as inconsistent drug policy or invite similar carve-out requests for other substances

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.